Cell line · CVCL_8787
Papers42
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 42
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity. | Cell Commun Signal | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Emerging role of ARHGAP29 in melanoma cell phenotype switching. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma. | Cell Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Human CSPG4-targeting CAR-macrophages inhibit melanoma growth. | Oncogene | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. | Genes Dev | 2025 | Its Methods give the RRID and name the line | PubMed | |
| GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| C19MC drives nucleolar invasion of mitochondria and meiotic nuclear division in human cancers. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. | Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| p300 KAT Regulates SOX10 Stability and Function in Human Melanoma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. | NAR Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion. | Nat Cell Biol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis. | Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ. | Cell Chem Biol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Mechanisms of Anticancer Activity of a Fatty Acid Mixture Extracted from Hen Egg Yolks Enriched in Conjugated Linoleic Acid Diene (CLA) against WM793 Melanoma Cells. | Nutrients | 2021 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_8787/papers